Biktarvy 50 mg/1
bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate · TABLET · A-S Medication Solutions
Biktarvy is a tablet containing bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate at 50 mg/1, taken oral. Manufactured by A-S Medication Solutions.
Key Facts
- Brand Name
- Biktarvy
- Generic Name
- bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate
- NDC Code (Product)
50090-6247- Manufacturer
- A-S Medication Solutions
- Strength
- 50 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- NDA210251
- Drug Class
- Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
- Marketing Start
- 02/07/2018
Recall History
No Recall HistoryFrequently Asked Questions
What is Biktarvy used for?
Biktarvy contains bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate. It is a tablet taken oral. Consult your doctor for specific uses.
Is Biktarvy a controlled substance?
Biktarvy is not classified as a controlled substance by the DEA.
What is the generic name for Biktarvy?
The generic name for Biktarvy is bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate. There are no other listed brand versions of bictegravir sodium, emtricitabine, and tenofovir alafenamide fumarate.
What is the NDC code for Biktarvy 50 mg/1?
The NDC (National Drug Code) for Biktarvy 50 mg/1 is 50090-6247, listed by A-S Medication Solutions.
Other Biktarvy Dosages
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)